| Lymphotoxin β receptor signaling |
0.00074131 |
9.68E−02 |
NFKBID, BCL2L1, CASP3, RELB, CXCL1 and TRAF1 |
| Agranulocyte adhesion and diapedesis |
0.001071519 |
5.73E−02 |
CXCL3, PODXL2, CCL4,CLDN19, CXCL14, CXCL1, CCL3L1/CCL3L3, MMP2, CXCL2, MYH7B and CCL4L1/CCL4L2 |
| Heme biosynthesis II |
0.001096478 |
1.67E−01 |
FECH, ALAS2, CPOX and HMBS |
| Hepatic fibrosis/hepatic stellate cell activation |
0.00162181 |
5.81E−02 |
CXCL3, LEPR, IL6R, MMP2, LBP, IL6, MYH7B, AGTR1 and PGF |
| Communication between innate and adaptive immune cells |
0.001995262 |
6.25E−02 |
CCL4, TLR7, CCL3L1/CCL3L3, CD83, IGHG1, IGHA1 and IL6 |
| Colorectal cancer metastasis signaling |
0.003467369 |
4.48E−02 |
BCL2L1, ADCY9, CDH1, JUN, CASP3, PTGER3, DIRAS3, IL6R, TLR7, MMP2, IL6 and PGF |
| IL-17A signaling in fibroblasts |
0.004570882 |
1E−01 |
NFKBID, JUN, IL6 and NFKBIZ |
| Toll-like receptor signaling |
0.004570882 |
7.81E−02 |
JUN, TLR7, TNFAIP3, LBP and TRAF1 |
| Differential regulation of cytokine production in macrophages and T-helper cells by IL-17A and IL-17F |
0.004786301 |
1.67E−01 |
CCL4, CXCL1 and IL6 |
| Granulocyte adhesion and diapedesis |
0.007762471 |
4.95E−02 |
CXCL3, CCL4, CLDN19, CXCL14, CXCL1, CCL3L1/CCL3L3, MMP2, CXCL2 and CCL4L1/CCL4L2 |
| Airway pathology in chronic obstructive pulmonary disease |
0.009772372 |
1.82E−01 |
CXCL3 and MMP2 |
| TNFR2 signaling |
0.016595869 |
8.82E−02 |
JUN, TNFAIP3 and TRAF1 |
| Heme bosynthesis from uroporphyrinogen-III I |
0.018620871 |
1.82E−01 |
FECH and CPOX |
| Aryl hydrocarbon receptor signaling |
0.024547089 |
4.09E−02 |
TGM2, CCNE1, GSTM2, ALDH1A1, JUN, NQO2 and IL6 |
| NRF2-mediated oxidative stress response |
0.025118864 |
4.1E−02 |
GSR, JUN, GSTM2, NQO2, DNAJC6, JUND, FOSL1 and ABCC4 |
| Role of IL-17A in psoriasis |
0.025703958 |
1.43E−01 |
CXCL3 and CXCL1 |
| Gα12/13 signaling |
0.028840315 |
4.72E−02 |
BTK, CDH7, CDH1, JUN, MEF2D and CDH11 |
| Tetrapyrrole biosynthesis II |
0.029512092 |
1.43E−01 |
ALAS2 and HMBS |
| CDK5 signaling |
0.033884416 |
5.15E−02 |
FOSB, PPP1CC, ADCY9, PPM1J and EGR1 |
| CD40 signaling |
0.033884416 |
5.63E−02 |
JUN, TNFAIP3, MAPKAPK2 and TRAF1 |
| Mitotic roles of polo-like kinase |
0.041686938 |
5.41E−02 |
PLK3, PPM1J, ANAPC13 and CCNB1 |
| Adenine and adenosine salvage III |
0.042657952 |
1.18E−01 |
PNP and ADAT3 |
| Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde |
0.046773514 |
1.11E−01 |
HAAO and KYNU |
| T-helper cell differentiation |
0.047863009 |
5.56E−02 |
STAT4, IL6R, IL6 and RORC |
